Announcements Trials

Browse Landscape

Phase

Status

Completed 15 Withdrawn 1 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 57 Carcinoma, Non-Small-Cell Lung 29 Breast Neoplasms 18 Rectal Neoplasms 14 Ovarian Neoplasms 14 Carcinoma, Hepatocellular 10 Neoplasm Metastasis 9 Glioblastoma 9 Colonic Neoplasms 9 Carcinoma, Renal Cell 8 Uterine Cervical Neoplasms 7 Fallopian Tube Neoplasms 7 Brain Neoplasms 6 Neoplasms 5 Nasopharyngeal Carcinoma 5 Lung Neoplasms 5 Triple Negative Breast Neoplasms 4 Recurrence 4 Liver Neoplasms 4 Inflammatory Breast Neoplasms 4 Colorectal Cancer Metastatic 4 Carcinoma, Ovarian Epithelial 4 Stomach Neoplasms 3 Pleural Effusion, Malignant 3 Meningeal Carcinomatosis 3 Melanoma 3 Kidney Neoplasms 3 Glioma 3 Non-squamous Non-small Cell Lung Cancer 2 Liver Metastasis Colon Cancer 2

Interventions

Docetaxel 5 Pemetrexed 4 Capecitabine 4 pembrolizumab 3 Oxaliplatin 3 icotinib 2 Radiation 2 Paclitaxel 2 Gemcitabine 2 Gefitinib 2 Fluorouracil 2 Drug Therapy 2 Chemoradiotherapy 2 Carboplatin 2 sintilimab 1 rucaparib 1 regorafenib 1 olaparib 1 lenvatinib 1 iron isomaltoside 1000 1 ipatasertib 1 iopromide 1 gluconic acid 1 elemene 1 capecitabine-irinotecan combination 1 aumolertinib 1 atezolizumab 1 anlotinib 1 aflutinib 1 XELOX 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Adenocarcinoma × Bevacizumab × Clear all

NCT04739202 2021-03-29

IMMUNOGAST

Hospices Civils de Lyon

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡